Real Questions, Expert-Informed Answers
9,214 answers to real cancer questions, grounded in published medical literature and NCCN guidelines.
Showing 462 answers for Lymphoma — page 10 of 10
Recurred. How does this change my treatment choices, and are new targeted therapies using biomarkers (CD20, PD-L1)...
According to the NCCN Guidelines for Relapsed/Refractory Lymphoma 2023, treatment options depend on several factors, including: - The specific type of lymphoma you have - Time sinc
Are checkpoint inhibitors relevant to lymphoma
Yes, checkpoint inhibitors are definitely relevant for certain types of lymphoma. Let me break this down with specific sources: According to the National Comprehensive Cancer Netw
What are the latest treatment options for lymphoma
Non-Hodgkin, and specific subtype, I'll provide a general overview from trusted sources. According to the National Comprehensive Cancer Network NCCN Guidelines, the main treatment
Are there clinical trials suitable for treating recurrent Lymphoma, and how can I determine if I am eligible
According to the National Cancer Institute NCI, clinical trials are often excellent options for patients with recurrent lymphoma, as they provide access to the newest treatments an
What is the myc biomarker? Does this relate to double hit
According to the National Comprehensive Cancer Network NCCN Guidelines for B-Cell Lymphomas: - MYC is a gene that helps control cell growth and division - When the MYC gene becomes
In more detail what each of these biomarker tests are measuring and how they inform treatment decisions for my type...
According to the NCCN Guidelines for Patients with Follicular Lymphoma 2024, accurate testing is absolutely essential for both diagnosing and determining the right treatment approa
How can I monitor progression from marginal zone to dlbcl? How might I predict my likelihood to progress - any factors
To monitor progression from marginal zone lymphoma MZL to diffuse large B-cell lymphoma DLBCL, the following strategies are recommended based on guidelines from trusted sources: 1
What are the treatment options for stage II prostate cancer
For stage II prostate cancer, the National Comprehensive Cancer Network NCCN Guidelines provide recommendations on treatment options. According to the NCCN Guidelines for Patients
Indolent b cell lymphoma
Indolent B-cell lymphomas are a group of slow-growing subtypes of non-Hodgkin lymphoma that affect B lymphocytes a type of white blood cell. Some key points about indolent B-cell
What resources or support services are available to help me and my loved ones cope with the emotional and practical...
Let me share some evidence-based resources and support services available to you and your loved ones. According to the Leukemia & Lymphoma Society LLS, several key support service
What is cd 20 and how does it impact how I should think about treatment for follicular lymphoma
According to the Leukemia & Lymphoma Society LLS, CD20 is a protein found on the surface of most B-cell lymphomas, including follicular lymphoma. Think of it as a kind of "marker"
How about grade 3b specifically? want to know about that
Based on the provided NCCN Guidelines for Diffuse Large B-Cell Lymphomas 2025, I can provide some specific information about Follicular Lymphoma Grade 3B FL3B: According to the NC
Don't see your question?
Ask Navis — our AI — about your specific cancer situation.
Ask Your Own Question